|
Tissue Engineering Part A
In Vivo Osteogenic Differentiation of Human Adipose-Derived Stem Cells in an Injectable In Situ–Forming Gel Scaffold
To cite this article:
Hyun Hee Ahn, Kyung Sook Kim, Jung Hwa Lee, Ju Young Lee, Byung Soo Kim, Il Woo Lee, Heung Jae Chun, Jae Ho Kim, Hai Bang Lee, Moon Suk Kim.
Tissue Engineering Part A.
July 2009,
15(7): 1821-1832.
doi:10.1089/ten.tea.2008.0386.
Hyun Hee Ahn, M.S., 1,2,**These authors contributed equally to this paper. Jung Hwa Lee, M.S.,1 Ju Young Lee, M.S.,1 Byung Soo Kim, M.S.,1 Il Woo Lee, M.D., Ph.D.,2 Heung Jae Chun, Ph.D.,3 Jae Ho Kim, Ph.D.,4 Hai Bang Lee, Ph.D.,1 and Moon Suk Kim, Ph.D.1,4 1Fusion Biotechnology Research Center, Korea Research Institute of Chemical Technology, Daejeon, Korea. 2Department of Neurosurgery, Catholic University of Korea, Daejeon, Korea. 3Department of Biomedical Sciences, College of Medicine, Catholic University, Seoul, Korea. 4Department of Molecular Science and Technology, Ajou University, Suwon, Korea. Address correspondence to: Moon Suk Kim, Ph.D. Department of Molecular Science and Technology Ajou UniversitySuwon 443-759 Korea E-mail: 8 7 2008 Received: July 8, 2008 7 11 2008 Accepted: November 7, 2008 The sol-to-gel transition occurring at around body temperature makes the MPEG-PCL diblock copolymer an ideal candidate material for use as an injectable in situ–forming gel containing human adipose tissue–derived stem cells (hADSCs). The sol can be prepared at room temperature, and the gel forms at body temperature. Solutions of the copolymer containing hADSCs and osteogenic factors injected into rats formed gel scaffolds at the injection sites. The gels thus formed showed the interconnective pore structure required to support growth, proliferation, and differentiation of hADSCs. Bromodeoxyuridine-labeled hADSCs were confirmed to be present in gels formed in vivo. Bone formation was observed only in gel implants containing both hADSCs and osteogenic factors. Subcutaneous implantation of the in situ–forming gel scaffold demonstrated that hADSCs embedded in the gel stimulated much lower host tissue responses than did the gel alone, probably because of the unique immunomodulatory properties of hADSCs. In conclusion, our data on hADSCs embedded in an in situ gel scaffold suggest that this formulation may provide numerous benefits as a noninvasive alternative for tissue-engineered bone formation. 
|
|